Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Akito Hata
Spatiotemporal T790M Heterogeneity in a Patient With EGFR-Mutant Non–Small-Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
How Sensitive Are Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitors for Squamous Cell Carcinoma of the Lung Harboring EGFR Gene–Sensitive Mutations?
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Afatinib Plus Bevacizumab Combination After Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in EGFR -Mutant Non-Small Cell Lung Cancer: Multicenter, Single-Arm, Phase 2 Trial (ABC Study)
Cancer
Cancer Research
Oncology
Phase I Study of Vorinostat With Gefitinib in BIM Deletion Polymorphism/Egfr Mutation Double‐positive Lung Cancer
Cancer Science
Cancer Research
Medicine
Oncology
Does Afatinib Plus Bevacizumab Combination Therapy Induce Positive Conversion of T790M in Previously-Negative Patients?
Oncotarget
Oncology
Osimertinib With Ramucirumab in EGFR Mutated, T790m-Positive Patients Who Had Progressed EGFR-TKIs: Phase Ib Study
Clinical Lung Cancer
Cancer Research
Oncology
Respiratory Medicine
Pulmonary
Validation of an Ion Torrent Sequencing Platform for the Detection of Gene Mutations in Biopsy Specimens From Patients With Non-Small-Cell Lung Cancer
PLoS ONE
Multidisciplinary
A Multi-Center, Phase II Trial of Nab-Paclitaxel and Gemcitabine in Patients With Non-Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy
Cancer Management and Research
Oncology
Gefitinib for a Poor Performance Status Patient With Squamous Cell Carcinoma of the Lung Harboring EGFR Mutation
Internal Medicine
Internal Medicine
Medicine
